These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15720237)

  • 1. Amyloidosis and auto-inflammatory syndromes.
    Grateau G; Jéru I; Rouaghe S; Cazeneuve C; Ravet N; Duquesnoy P; Cuisset L; Dodé C; Delpech M; Amselem S
    Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):57-65. PubMed ID: 15720237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Musculoskeletal disorders in secondary amyloidosis and hereditary fevers.
    Grateau G
    Best Pract Res Clin Rheumatol; 2003 Dec; 17(6):929-44. PubMed ID: 15123044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amyloidosis AA].
    Stankovic K; Grateau G
    Nephrol Ther; 2008 Jul; 4(4):281-7. PubMed ID: 18514052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Auto-inflammatory syndromes].
    Grateau G
    Rev Prat; 2005 Feb; 55(4):353-9. PubMed ID: 15828611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoinflammatory diseases.
    Grateau G
    Acta Clin Belg; 2006; 61(5):264-9. PubMed ID: 17240743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic aspects of the hereditary periodic fever syndromes.
    Grateau G
    Rheumatology (Oxford); 2004 Apr; 43(4):410-5. PubMed ID: 14983109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
    Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AA amyloidosis complicating the hereditary periodic fever syndromes.
    Lane T; Loeffler JM; Rowczenio DM; Gilbertson JA; Bybee A; Russell TL; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Arthritis Rheum; 2013 Apr; 65(4):1116-21. PubMed ID: 23280696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic AA amyloidosis induced by benign neoplasms].
    Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
    Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostics and therapy of AA amyloidosis].
    Blank N; Lorenz HM
    Pathologe; 2009 May; 30(3):219-25. PubMed ID: 19333604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation-responsive transcription factor SAF-1 activity is linked to the development of amyloid A amyloidosis.
    Ray A; Shakya A; Kumar D; Benson MD; Ray BK
    J Immunol; 2006 Aug; 177(4):2601-9. PubMed ID: 16888022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.
    Ugurlu S; Hacioglu A; Adibnia Y; Hamuryudan V; Ozdogan H
    Orphanet J Rare Dis; 2017 May; 12(1):105. PubMed ID: 28558744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auto-inflammatory syndromes and oral health.
    Scully C; Hodgson T; Lachmann H
    Oral Dis; 2008 Nov; 14(8):690-9. PubMed ID: 19193198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary periodic fever and reactive amyloidosis.
    van der Hilst JC; Simon A; Drenth JP
    Clin Exp Med; 2005 Oct; 5(3):87-98. PubMed ID: 16284730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of the levels of acute phase reactants for the prediction of familial Mediterranean fever associated amyloidosis: a case control study.
    Yalçinkaya F; Cakar N; Acar B; Tutar E; Güriz H; Elhan AH; Oztürk S; Kansu A; Ince E; Atalay S; Girgin N; Doğru U; Aysev D; Ekim M
    Rheumatol Int; 2007 Apr; 27(6):517-22. PubMed ID: 17103173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine use in isolated renal AA amyloidosis.
    Meneses CF; Egües CA; Uriarte M; Belzunegui J; Rezola M
    Reumatol Clin; 2015; 11(4):242-3. PubMed ID: 25453598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of renal AA amyloidosis in familial Mediterranean fever with pegylated alpha-2a interferon.
    Vandecasteele SJ; De Paepe P; De Vriese AS
    Clin Nephrol; 2011 Feb; 75 Suppl 1():1-3. PubMed ID: 21269584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AA amyloidosis: basic knowledge, unmet needs and future treatments.
    Obici L; Merlini G
    Swiss Med Wkly; 2012; 142():w13580. PubMed ID: 22653707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse pulmonary amyloidosis that mimics interstitial lung disease in a patient with familial Mediterranean fever.
    Erdem H; Simşek I; Pay S; Dinc A; Deniz O; Ozcan A
    J Clin Rheumatol; 2006 Feb; 12(1):34-6. PubMed ID: 16484879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.